Digital Scent Technology Market Report 2024: Emerging Technologies
The global digital scent technology market size is estimated to USD 1.2 billion in 2024 and is projected to reach USD 2.0 billion by 2029, growing at a CAGR of 10.5% during the forecast period.
The growth of market is driven by the growing adoption of e-noses in food industry for process monitoring. freshness evaluation, and authenticity assessment, rising adoption of compact, portable, and loT-enabled e-noses, growing deployment of e-nose devices for diagnosing diseases, and integration of e-noses and synthesizers into smart homes.
Download Ultimate PDF Guide:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=118670062
Top Key Players:
Siemens (Germany), Amphenol Corporation (US), Sensirion AG (Switzerland), Honeywell International Inc. (US), Renesas Electronics Corporation (Japan), Envirosuite Ltd (Australia), Alpha MOS (France), Electronic Sensor Technology (US), Aromajoin Corporation (Japan), Figaro Engineering Inc. (US), Bosch Sensortec GmbH (Germany), and Alphasense (UK).
The digital scent technology market in North America is estimated to account for largest share during the forecast period.
Increase in healthcare expenditure in North America has propelled the importance on enhancing patient care, diagnosis, and treatment processes. The integration of digital scent technology and e-noses can offer innovative solutions, particularly in healthcare facilities. The substantial increase in Medicare and Medicaid spending further underscores the government's commitment to healthcare, providing opportunities for technology adoption. Bio-sensing is one of the applications that is being used extensively in the healthcare industry. Biosensors are mainly used in the healthcare industry to recognize and track the physiological processes inside the body. It is used for the critical secondary and tertiary analysis of the physiological mechanisms.
The digital scent technology market for e-nose segment to hold largest market share during the forecast period.
Electronic noses (e-noses) emulate the human sense of smell using various sensor technologies and have applications in the medical and defense sectors. In the medical sector, they promise rapid, non-destructive disease diagnosis by analyzing breath, urine, or blood samples, enhancing treatment monitoring, and enabling personalized medicine.
Medical segment in application to the highest market share of the digital scent technology market during the forecast period
Digital scent technology is used in the medical segment for clinical diagnosis. Human odor as a result from internal hormonal or metabolic changes, contains a biomarker for various diseases and indicates the physiological status of an individual. The main sources of human odor are saliva, sweat, breath, urine, and skin. Recently, the components of skin emissions, exhaled breath, and urine odor have created attention as diagnostic biomarkers of diseases and disorders, including liver disease, lung cancer, diabetes, asthma, cystic fibrosis, and chronic obstructive pulmonary disease. Volatile organic compounds are the major target for e-noses in medical diagnosis, such as ammonia in individuals with liver disease, acetone for patients with diabetes, and alkanes in patients with lung cancer, pentane in patients with asthma. The e-nose technology has the potential to be operated for diagnosis.
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian